Shannon John Patrick Jr
See Remarks
Shannon John Patrick Jr has filed 4 SEC Form 4 filings (12 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Aug 21, 2026.
On the most recent filing, Shannon John Patrick Jr is listed as See Remarks at Xeris Biopharma Holdings, Inc. Inside the rolling window, Shannon John Patrick Jr reported no open-market purchases and 2 open-market sales totaling $350K in XERS. The largest disclosed transaction in the window is a sale of 24,907 XERS shares on Jan 5, 2026, worth $176K.
Companies traded
Other insiders at XERS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$350K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Shannon John Patrick Jr made?
Shannon John Patrick Jr has filed 4 SEC Form 4 filings (12 transaction rows) across 1 company since 2025.
Which companies does Shannon John Patrick Jr trade?
Shannon John Patrick Jr has filed SEC Form 4 disclosures for 1 company, including XERS.
When was Shannon John Patrick Jr's most recent SEC Form 4 filing?
Shannon John Patrick Jr's most recent SEC Form 4 filing on Tracefour is dated Aug 21, 2026.
What is Shannon John Patrick Jr's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Shannon John Patrick Jr is listed as See Remarks.
What is Shannon John Patrick Jr's total buy and sell value in the current window?
Inside the rolling retention window, Shannon John Patrick Jr bought $0 and sold $350K based on SEC Form 4 filings.
What was Shannon John Patrick Jr's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 24,907 XERS shares on 2026-01-05, worth $176K, per SEC Form 4 filings.